Abrams EM, McGill G, Bhopal SS, Sinha I, Fernandes RM. COVID-19, asthma, and return to school. Lancet Respir Med. 2020; 8:(9)847-849

Bodaghkhani E, Mahdavian M, MacLellan C, Farrell A, Asghari S. Effects of Meteorological Factors on Hospitalizations in Adult Patients with Asthma: A Systematic Review. Canadian Respiratory Journal. 2019; 2019

Bousquet J, Schünemann HJ, Togias A Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020; 145:(1)70-80.e3

British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN). BTS/SIGN British Guideline on the Management of Asthma. 2019. (accessed 4 April 2022)

Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008; 31:(2)320-325

D'Amato G, Holgate ST, Pawankar R Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization. World Allergy Organ J. 2015; 8:(1)

D'Amato G, Vitale C, Molino A Asthma-related deaths. Multidiscip Respir Med. 2016; 11

EUFOREA. Pocket guide – Allergic Rhinitis. 2021. (accessed 4 April 2022)

FitzGerald JM, Sears MR, Boulet LP Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J. 2003; 10:(8)427-434

Global Initiative for Asthma. Pocket Guide for asthma management and prevention. 2021. (accessed 4 April 2022)

Harun NS, Lachapelle P, Douglass J. Thunderstorm-triggered asthma: what we know so far. J Asthma Allergy. 2019; 12:101-108

Head K, Snidvongs K, Glew S Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev. 2018; 6:(6)

Hellings PW, Scadding G, Bachert C EUFOREA treatment algorithm for allergic rhinitis. Rhinology. 2020; 58:(6)618-622

Ind PW, Haughney J, Price D, Rosen JP, Kennelly J. Adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Respir Med. 2004; 98:(5)464-475

Janson C, Henderson R, Löfdahl M, Hedberg M, Sharma R, Wilkinson AJK. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2020; 75:(1)82-84

London Air. How bad is summer smog?. 2022. (accessed 4 April 2022)

Medicines and Healthcare Products Regulatory Agency. Off-label or unlicensed use of medicines: prescribers' responsibilities. 2014. (accessed 4 April 2022)

Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res. 2010; 690:(1-2)24-39

Royal College of Physicians. Why asthma still kills: The National Review of Asthma Deaths (NRAD). 2015. (accessed 14 April 2022)

National Institute of Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. 2017. (accessed 4 April 2022)

National Institute of Health and Care Excellence. What is the prevalence of asthma?. 2021. (accessed 4 February 2022)

O'Byrne PM, FitzGerald JM, Bateman ED Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N Engl J Med. 2018; 378:(20)1865-1876

Salciccioli JD, She L, Tulchinsky A, Rockhold F, Cardet JC, Israel E. Effect of COVID-19 on asthma exacerbation. J Allergy Clin Immunol Pract. 2021; 9:(7)2896-2899.e1

Satia I, Adatia A, Yaqoob S Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?. ERJ Open Res. 2020; 6:(4)

Sinyor B, Concepcion Perez L. Pathophysiology Of Asthma.Treasure Island (FL): StatPearls Publishing; 2021

Takemura M, Inoue D, Takamatsu K Co-existence and seasonal variation in rhinitis and asthma symptoms in patients with asthma. Respiratory Investigation. 2016; 54:(5)320-326

Yu HR, Lin CHR, Tsai JH A Multifactorial Evaluation of the Effects of Air Pollution and Meteorological Factors on Asthma Exacerbation. International Journal of Environmental Research and Public Health. 2020; 17:(11)

Zuberi FF, Haroon MA, Haseeb A, Khuhawar SM. Role of Montelukast in Asthma and Allergic rhinitis patients. Pak J Med Sci. 2020; 36:(7)1517-1522

Seasonal asthma: should it be managed differently?

02 May 2022
Volume 4 · Issue 5


Asthma is an inflammatory condition, which is usually associated with an allergic trigger and response. Seasonal changes can influence asthma morbidity and mortality. The aim of asthma management is to optimise symptom control by impacting of the inflammatory cascade and, where possible, avoidance of known allergens. Triggers for asthma symptoms can alter during the course of the year as weather and airborne allergens change with the seasons. People living with seasonal, allergic asthma should be taught to recognise their own triggers for their asthma symptoms and should be offered personalised, tailored advice, medication and action plans to proactively manage their asthma, optimise symptom control and prevent exacerbations.

Asthma is an inflammatory condition that affects approximately 12% of the population, or 8 million people, some of whom may be asymptomatic and off treatment. However, at any given time, around 5.4 million people are receiving treatment for asthma (National Institute for Health and Care Excellence [NICE], 2021). The diagnosis is made when a patient presents with typical symptoms of a cough, wheezing, tight chest and/or shortness of breath, along with other key elements such as a family history of asthma or a personal or family history of atopy, the presence of triggers and evidence of variable airflow obstruction which reverses with treatment (British Thoracic Society/Scottish Intercollegiate Guidelines Network [BTS/SIGN], 2019). The variability in symptoms can be evident in different ways – through the episodic nature of the symptoms, diurnal variation (symptoms are often worse during the night or in the early morning) or through seasonal changes (Global Initiative for Asthma [GINA], 2021).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month